Singapore, May 30 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascimi... Read More
Singapore, May 30 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with ... Read More
U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07616063) titled 'Subjective Assessment of Spatial Orientation Abilities in Alzheimer's Disease' on May 04. B... Read More
Singapore, May 30 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy v... Read More
Singapore, May 30 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy v... Read More
U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614737) titled 'Evaluation of Behaviour Intervention on Adherence and Periodontal Outcomes' on May 15. Brie... Read More
Singapore, May 30 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing BMS-986504 in Combination with Nab-paclitaxel an... Read More
U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07613385) titled 'Individualized AML Treatment' on May 18. Brief Summary: Every patient responds differently ... Read More
Singapore, May 30 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adj... Read More
Singapore, May 30 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant ... Read More